Literature DB >> 16042108

Congenital bilateral vocal cord paralysis and the role of glycine.

Robert G Berkowitz1, Qi-Jian Sun, Paul M Pilowsky.   

Abstract

OBJECTIVES: We sought to modify normal laryngeal constrictor (LC) motoneuron activity to induce a pattern of aberrant LC muscle function that may serve as a model of congenital bilateral vocal cord paralysis.
METHODS: Single unit extracellular recordings of functionally identified LC motoneurons were made in anesthetized Sprague-Dawley rats, and the response to both intravenous and iontophoretic application of the glycine antagonist strychnine was studied.
RESULTS: The postinspiratory firing pattern of LC motoneurons became inspiratory after intravenous injection of strychnine (4 of 5 rats), but no change was recorded in response to strychnine iontophoresis (7 of 8 rats).
CONCLUSIONS: Blockade of glycinergic inhibitory neurotransmission by strychnine, acting above the level of the LC motoneuron, causes LC motoneurons to fire during inspiration rather than after inspiration. This observation suggests that impaired glycine neurotransmission may be an underlying mechanism that explains the clinical manifestations of congenital bilateral vocal cord paralysis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16042108     DOI: 10.1177/000348940511400612

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  2 in total

1.  A computational study of the role of the aortic arch in idiopathic unilateral vocal-fold paralysis.

Authors:  Megan J Williams; Avinash Ayylasomayajula; Reza Behkam; Andrew J Bierhals; M Eileen Jacobs; Julia D Edgar; Randal C Paniello; Julie M Barkmeier-Kraemer; Jonathan P Vande Geest
Journal:  J Appl Physiol (1985)       Date:  2014-12-04

2.  Facial Palsy as Initial Symptom in Glycine Receptor Antibody Positive Progressive Encephalomyelitis With Rigidity and Myoclonus: A Case Report.

Authors:  Li Wang; Rui Zhang; Kai Liu; Yafang Xu; Bo Song; Yuming Xu
Journal:  Front Neurol       Date:  2022-04-25       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.